Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves’ Ophthalmopathy to Parenteral Corticosteroids

BackgroundHigh dose intravenous glucocorticoid (ivGC) therapy is the first line treatment in moderate to severe Graves’ ophthalmopathy (GO) and is associated with a clinical response rate ranging from 50% to 80%. Recently, a positive correlation between total cholesterol and low-density lipoproteins...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Adriano Naselli, Diletta Moretti, Concetto Regalbuto, Maria Luisa Arpi, Fabrizio Lo Giudice, Francesco Frasca, Antonino Belfiore, Rosario Le Moli
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-12-01
coleção:	Frontiers in Endocrinology
Assuntos:	cholesterol low-density lipoprotein cholesterol Graves’ ophthalmopathy parenteral corticosteroids Graves’ disease
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fendo.2020.609895/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!